Sort
50,496 grants matching “lung cancer”
TARGETING ROR1 WITH CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
$444,969Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
Proactive Prevention of Exposure Respirable Chromium
$444,962Els Technology, Inc. · R44 · FY2005 · ES
Tumor Cell Dependence on Host Metabolism
$444,948Eileen White · Rutgers, The State Univ Of N.J. · R01 · FY2018 · CA
Tissue and organ specific human B cell immunity
$444,936Frances E. Lund · University Of Alabama At Birmingham · U19 · FY2020 · AI
Tissue and organ specific human B cell immunity
$444,936Frances E. Lund · University Of Alabama At Birmingham · U19 · FY2021 · AI
Novel Reagents and New Biomarkers for Lung Cancer
$444,908Adi F Gazdar · Ut Southwestern Medical Center · U01 · FY2006 · CA
Exosome secretion in breast cancer progression
$444,908Alissa M Weaver · Vanderbilt University · R01 · FY2023 · CA
Exosome secretion in breast cancer progression
$444,905Alissa M Weaver · Vanderbilt University · R01 · FY2022 · CA
Identifying intercellular circuits driving cell phenotypes within a niche
$444,899Lonnie D Shea · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Developmental Funds
$444,880Caryn Lerman · University Of Southern California · P30 · FY2022 · CA
Camptothecin Analogs for Cancer Therapy
$444,873Lee Roy Morgan · Dekk-Tec, Inc. · R44 · FY2010 · CA
Interdisciplinary Training Program in Lung Disease
$444,817Claude A Piantadosi · Duke University · T32 · FY2016 · HL
Development of statistical genetics methodology
$444,812Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2012 · HG
Cyclin A Function in Normal Proliferation and in Neoplasia
$444,799Piotr Sicinski · Dana-Farber Cancer Inst · R01 · FY2009 · CA
Discovery of novel PCFT-targeted agents
$444,742Larry H. Matherly · Wayne State University · R01 · FY2014 · CA
Prospective Study of Human Oral Microbiome and Pancreatic Cancer Risk
$444,726Jiyoung Ahn · New York University School Of Medicine · R01 · FY2014 · CA
Development and application of non-thermal high frequency IRE to treat hepatic tumors
$444,672Rafael Vidal Davalos · Virginia Polytechnic Inst And St Univ · R01 · FY2023 · CA
Molecular Diagnostics Core Laboratory
$444,657Mark Raffeld · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
The Role of Epithelial-Mesenchymal Transition in Re-Wiring KRAS Mutant Lung Cancer
$444,653Don Lynn Gibbons · University Of Tx Md Anderson Can Ctr · R37 · FY2021 · CA
Anti-tumor potential of temperature-sensitive p53 mutants
$444,591Jiandong Chen · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA
Anti-tumor potential of temperature-sensitive p53 mutants
$444,590Jiandong Chen · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · CA
Targeting vulnerabilities in copper metabolism in the development of cancer therapies
$444,564Michael J Petris · University Of Missouri-Columbia · R01 · FY2022 · CA
A Randomized Trial of Incentives for Research Participation
$444,555Scott D Halpern · University Of Pennsylvania · R01 · FY2015 · CA
Personalized Risk-AdaptIve Surveillance strategies in cancEr -- PRAISE
$444,555Aasthaa Bansal · University Of Washington · R37 · FY2021 · CA
Resolution of Epithelial Cell Hyperplasia
$444,506Yohannes Tesfaigzi · Lovelace Biomedical & Environmental Research Institute · R01 · FY2009 · ES